|
1
|
Thorne AH, Meisen WH, Russell L, Yoo JY,
Bolyard CM, Lathia JD, Rich J, Puduvalli VK, Mao H, Yu J, et al:
Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated
oncolytic herpes simplex virus clearance. Mol Ther. 22:1678–1687.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1996.
|
|
5
|
Lu J, Liu X, Zheng J, Song J, Liu Y, Ruan
X, Shen S, Shao L, Yang C, Wang D, et al: Lin28A promotes
IRF6-regulated aerobic glycolysis in glioma cells by stabilizing
SNHG14. Cell Death Dis. 11(447)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Castro-Oropeza R, Melendez-Zajgla J,
Maldonado V and Vazquez-Santillan K: The emerging role of lncRNAs
in the regulation of cancer stem cells. Cell Oncol (Dordr).
41:585–603. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shi J, Dong B, Cao J, Mao Y, Guan W, Peng
Y and Wang S: Long non-coding RNA in glioma: Signaling pathways.
Oncotarget. 8:27582–27592. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cui B, Li B, Liu Q and Cui Y: lncRNA CCAT1
promotes glioma tumorigenesis by sponging miR-181b. J Cell Biochem.
118:4548–4557. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liao Y, Shen L, Zhao H, Liu Q, Fu J, Guo
Y, Peng R and Cheng L: LncRNA CASC2 interacts with miR-181a to
modulate glioma growth and resistance to TMZ through PTEN pathway.
J Cell Biochem. 118:1889–1899. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shao M, Liu W and Wang Y: Differentially
expressed LncRNAs as potential prognostic biomarkers for
glioblastoma. Cancer Genet. 226-227:23–29. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Z, Liu H, Zhong Q, Wu J and Tang Z:
LncRNA UCA1 is necessary for TGF-beta-induced
epithelial-mesenchymal transition and stemness via acting as a
ceRNA for Slug in glioma cells. FEBS Open Bio. 8:1855–1865.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sun WL, Kang T, Wang YY, Sun JP, Li C, Liu
HJ, Yang Y and Jiao BH: Long noncoding RNA OIP5-AS1 targets Wnt-7b
to affect glioma progression via modulation of miR-410. Biosci Rep.
39(BSR20180395)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu X, Wang Y, Yu T, Nie E, Hu Q, Wu W, Zhi
T, Jiang K, Wang X, Lu X, et al: Blocking MIR155HG/miR-155 axis
inhibits mesenchymal transition in glioma. Neuro Oncol.
19:1195–1205. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fu C, Li D, Zhang X, Liu N, Chi G and Jin
X: LncRNA PVT1 facilitates tumorigenesis and progression of glioma
via regulation of MiR-128-3p/GREM1 axis and BMP signaling pathway.
Neurotherapeutics. 15:1139–1157. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu SH, Zhu JW, Xu HH, Zhang GQ, Wang Y,
Liu YM, Liang JB, Wang YX, Wu Y and Guo QF: A novel antisense long
non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and
increases cell proliferation and growth. Mol Cell Biochem.
430:47–56. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang YQ, Jiang DM, Hu SS, Zhao L, Wang L,
Yang MH, Ai ML, Jiang HJ, Han Y, Ding YQ and Wang S: SATB2-AS1
suppresses colorectal carcinoma aggressiveness by inhibiting
SATB2-dependent snail transcription and epithelial-mesenchymal
transition. Cancer Res. 79:3542–3556. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cheng S, Xia B, Li H, Li Y, Lv X, Zhang Y
and Huang Y: Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p
to suppress breast cancer cell growth by promoting breast cancer
metastasis suppressor 1-like. Cancer Cell Int.
20(321)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Huang J, Yang Y, Zhao F, Zhang Z, Deng J,
Lu W and Jiang X: LncRNA SATB2-AS1 overexpression represses the
development of hepatocellular carcinoma through regulating the
miR-3678-3p/GRIM-19 axis. Cancer Cell Int. 23(82)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhou Y, Li W, Xu Q and Huang Y: Elevated
expression of Dickkopf-1 increases the sensitivity of human glioma
cell line SHG44 to BCNU. J Exp Clin Cancer Res.
29(131)2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu J, Jiang J, Hui X, Wang W, Fang D and
Ding L: Mir-758-5p suppresses glioblastoma proliferation, migration
and invasion by targeting ZBTB20. Cell Physiol Biochem.
48:2074–2083. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu F, Wu H, Wu G, Long J, Dai J and Wang
Z: circPKD2 inhibits the glioma cell proliferation, invasion and
glycolytic metabolism through regulating the miR-1278/LATS2 axis.
Neurosci Lett. 801(137126)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jin Z, Piao L, Sun G, Lv C, Jing Y and Jin
R: Long non-coding RNA PART1 exerts tumor suppressive functions in
glioma via sponging miR-190a-3p and inactivation of PTEN/AKT
pathway. Onco Targets Ther. 13:1073–1086. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tong L, Chu M, Yan B, Zhao W, Liu S, Wei
W, Lou H, Zhang S, Ma S, Xu J and Wei L: MTDH promotes glioma
invasion through regulating miR-130b-ceRNAs. Oncotarget.
8:17738–17749. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Barbagallo D, Condorelli A, Ragusa M,
Salito L, Sammito M, Banelli B, Caltabiano R, Barbagallo G, Zappalà
A, Battaglia R, et al: Dysregulated miR-671-5p/CDR1-AS/CDR1/VSNL1
axis is involved in glioblastoma multiforme. Oncotarget.
7:4746–4759. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou M, Zhang Z, Zhao H, Bao S, Cheng L
and Sun J: An immune-related six-lncRNA signature to improve
prognosis prediction of glioblastoma multiforme. Mol Neurobiol.
55:3684–3697. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang Q, Zhang J, Liu Y, Zhang W, Zhou J,
Duan R, Pu P, Kang C and Han L: A novel cell cycle-associated
lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA
transcript and is a biomarker of progression in glioma. Cancer
Lett. 373:251–259. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Huang L, Jiang X, Wang Z, Zhong X, Tai S
and Cui Y: Small nucleolar RNA host gene 1: A new biomarker and
therapeutic target for cancers. Pathol Res Pract. 214:1247–1252.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lei B, Yu L, Jung TA, Deng Y, Xiang W, Liu
Y and Qi S: Prospective series of nine long noncoding RNAs
associated with survival of patients with glioblastoma. J Neurol
Surg A Cent Eur Neurosurg. 79:471–478. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhaohui W, Yingli N, Hongli L, Haijing W,
Xiaohua Z, Chao F, Liugeng W, Hui Z, Feng T, Linfeng Y and Hong J:
Amentoflavone induces apoptosis and suppresses glycolysis in glioma
cells by targeting miR-124-3p. Neurosci Lett. 686:1–9.
2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu Y, Hou X, Liu M, Yang Z, Bi Y, Zou H,
Wu J, Che H, Li C, Wang X, et al: XBP1 silencing decreases glioma
cell viability and glycolysis possibly by inhibiting HK2
expression. J Neurooncol. 126:455–462. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
He Z, You C and Zhao D: Long non-coding
RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated
stromal cells-mediated glycolysis and invasion of glioma cells.
Biochem Biophys Res Commun. 500:569–576. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shi J, Zhang Y, Qin B, Wang Y and Zhu X:
Long non-coding RNA LINC00174 promotes glycolysis and tumor
progression by regulating miR-152-3p/SLC2A1 axis in glioma. J Exp
Clin Cancer Res. 38(395)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K,
Liu X, Xu T, Sun L, Qin J, et al: LncRNA SATB2-AS1 inhibits tumor
metastasis and affects the tumor immune cell microenvironment in
colorectal cancer by regulating SATB2. Mol Cancer.
18(135)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ghafouri-Fard S, Askari A, Hussen BM,
Rasul MF, Hatamian S, Taheri M and Kiani A: A review on the role of
miR-671 in human disorders. Front Mol Biosci.
9(1077968)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li X and Diao H: Circular RNA circ_0001946
acts as a competing endogenous RNA to inhibit glioblastoma
progression by modulating miR-671-5p and CDR1. J Cell Physiol.
234:13807–13819. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wu Q, Yin X, Zhao W, Xu W and Chen L:
Molecular mechanism of m6A methylation of circDLC1 mediated by RNA
methyltransferase METTL3 in the malignant proliferation of glioma
cells. Cell Death Discov. 8(229)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Dropcho EJ, Chen YT, Posner JB and Old LJ:
Cloning of a brain protein identified by autoantibodies from a
patient with paraneoplastic cerebellar degeneration. Proc Natl Acad
Sci USA. 84:4552–4556. 1987.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Guerrico AM, Jaffer ZM, Page RE,
Braunewell KH, Chernoff J and Klein-Szanto AJ: Visinin-like
protein-1 is a potent inhibitor of cell adhesion and migration in
squamous carcinoma cells. Oncogene. 24:2307–2316. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fu J, Jin F, Zhang J, Fong K, Bassi DE,
Lopez De Cicco R, Ramaraju D, Braunewell KH, Conti C, Benavides F
and Klein-Szanto AJ: VILIP-1 expression in vivo results in
decreased mouse skin keratinocyte proliferation and tumor
development. PLoS One. 5(e10196)2010.PubMed/NCBI View Article : Google Scholar
|
